An Open-Label Study to Evaluate the Efficacy and Safety of TMC207 in Subjects With Multibacillary Leprosy
Phase of Trial: Phase II
Latest Information Update: 04 Jan 2019
At a glance
- Drugs Bedaquiline (Primary)
- Indications Leprosy
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 27 Dec 2018 Planned End Date changed from 7 Jul 2021 to 21 Sep 2021.
- 09 Oct 2018 Planned End Date changed from 22 Apr 2021 to 7 Jul 2021.
- 09 Oct 2018 Status changed from not yet recruiting to recruiting.